Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 22-Nov-24
Select bar for recommendation details.
Recommendations | 22-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Catalyst Pharmaceuticals Inc have a median target of 31.00, with a high estimate of 38.00 and a low estimate of 28.00. The median estimate represents a 46.78% increase from the last price of 21.12.
High | 79.9% | 38.00 |
Med | 46.8% | 31.00 |
Low | 32.6% | 28.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 26, 2025.
Average growth rate | +13.68% |
Average growth rate | +43.87% |
More ▼
Revenue history & estimates in USD
Average growth rate | +6.55% |
Average growth rate | +43.17% |
More ▼